Showing results (31-40 of 56) with videos related to

Sort By:
Pageof 6
Blood Advances|July 11, 2022
Outcomes of allogeneic hematopoietic cell transplantation in adults with fusions associated with Ph-like ALLIbrahim Aldoss, Dongyun Yang, Vanina Tomasian, et al.
Leukemia|June 26, 2026
Plasticity under pressure: biology and detection of lineage switch in acute leukemiaAlexandra E Kovach, Yang-Yang Ding, Adam J Lamble, et al.
Blood Advances|January 17, 2025
TP53 mutations are associated with CD19- relapse and inferior outcomes after blinatumomab in adults with ALLIbrahim Aldoss, Shanpeng Li, Jianying Zhang, et al.
American Journal of Hematology|March 7, 2023
High response rates and transition to transplant after novel targeted and cellular therapies in adults with relapsed/refractory acute lymphoblastic leukemia with Philadelphia-like fusionsIbrahim Aldoss, Michelle Afkhami, Dongyun Yang, et al.
Haematologica|November 7, 2024
Venetoclax in combination with a pediatric-inspired regimen for the treatment of newly diagnosed adults with Philadelphia chromosome-negative acute lymphoblastic leukemiaIbrahim Aldoss, Jianying Zhang, Kathryn Shimamoto, et al.
Blood|July 13, 2018
Genomic and outcome analyses of Ph-like ALL in NCI standard-risk patients: a report from the Children's Oncology GroupKathryn G Roberts, Shalini C Reshmi, Richard C Harvey, et al.
Nature Communications|December 15, 2021
Interleukin-7 receptor α mutational activation can initiate precursor B-cell acute lymphoblastic leukemiaAfonso R M Almeida, João L Neto, Ana Cachucho, et al.
The Lancet. Haematology|June 27, 2020
Hyper-CVAD regimen in combination with ofatumumab as frontline therapy for adults with Philadelphia chromosome-negative B-cell acute lymphoblastic leukaemia: a single-arm, phase 2 trialElias Jabbour, Guillaume Richard-Carpentier, Yuya Sasaki, et al.
Nature Cancer|June 26, 2026
Inhibition of ADSS2-mediated de novo AMP biosynthesis re-sensitizes acute myeloid leukemia to BH3 mimeticsXin He, Lei Zhang, Yang Li, et al.
Science Translational Medicine|March 29, 2023
Phosphorylation stabilized TET1 acts as an oncoprotein and therapeutic target in B cell acute lymphoblastic leukemiaZhenhua Chen, Keren Zhou, Jianhuang Xue, et al.
Pageof 6